Transformation of the microvascular system during multistage tumorigenesis
暂无分享,去创建一个
[1] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[2] J. Werner,et al. Vascular structure and microcirculation of experimental pancreatic carcinoma in rats. , 2000, The European journal of surgery = Acta chirurgica.
[3] R K Jain,et al. Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.
[4] J. Werner,et al. Reduced basal and stimulated leukocyte adherence in tumor endothelium of experimental pancreatic cancer , 1999, International journal of pancreatology : official journal of the International Association of Pancreatology.
[5] D. Granger,et al. Quantification of murine endothelial cell adhesion molecules in solid tumors. , 1999, American journal of physiology. Heart and circulatory physiology.
[6] P. Meltzer,et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.
[7] G. Hämmerling,et al. Autoaggression and tumor rejection: it takes more than self‐specific T‐cell activation , 1999, Immunological reviews.
[8] D. Hanahan,et al. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.
[9] D. Hanahan,et al. Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes. , 1998, Cancer research.
[10] N. Weidner,et al. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow , 1998, The Journal of pathology.
[11] Thomas Boehm,et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.
[12] Rakesh K. Jain,et al. Quantitative angiogenesis assays: Progress and problems , 1997, Nature Medicine.
[13] T Klyscz,et al. [Cap image--a new kind of computer-assisted video image analysis system for dynamic capillary microscopy]. , 1997, Biomedizinische Technik. Biomedical engineering.
[14] William Arbuthnot Sir Lane,et al. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.
[15] D. Hanahan,et al. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. , 1996, Genes & development.
[16] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[17] G. Groenewegen,et al. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. , 1996, Blood.
[18] J. Folkman,et al. Angiostatin induces and sustains dormancy of human primary tumors in mice , 1996, Nature Medicine.
[19] G. Groenewegen,et al. Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. , 1996, Cancer research.
[20] E. Lander,et al. Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma. , 1995, Cancer research.
[21] H. Buhr,et al. Intravenous Contrast Medium Aggravates the Impairment of Pancreatic Microcirculation in Necrotizing Pancreatitis in the Rat , 1995, Annals of surgery.
[22] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[23] M. Dewhirst,et al. Diminished leukocyte-endothelium interaction in tumor microvessels. , 1992, Cancer research.
[24] D. Bates,et al. Intravital video‐capillaroscopy for the study of the microcirculation in psoriasis , 1992, The British journal of dermatology.
[25] D. Ingber,et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth , 1990, Nature.
[26] D. Hanahan,et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.
[27] R K Jain,et al. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. , 1988, Cancer research.
[28] R K Jain,et al. Determinants of tumor blood flow: a review. , 1988, Cancer research.
[29] D. Hanahan,et al. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. , 1985, Nature.
[30] L. Orci,et al. New Perspectives on the Microvasculature of the Islets of Langerhans in the Rat , 1982, Diabetes.
[31] S. Brem,et al. Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. , 1977, Science.
[32] Dian Feng,et al. Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor , 2000, Laboratory Investigation.
[33] R. Sutherland. Tumor hypoxia and gene expression--implications for malignant progression and therapy. , 1998, Acta oncologica.
[34] N. Bouck,et al. How tumors become angiogenic. , 1996, Advances in cancer research.
[35] D. Hanahan,et al. Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice. , 1996, The Journal of clinical investigation.
[36] R. Jain,et al. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. , 1996, Nature medicine.
[37] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[38] C. Streffer,et al. The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. I. Vascular corrosion casting studies. , 1989, Acta anatomica.